Phibro Animal Health

Phibro Animal Health

PAHC· Manufacturing· Fiscal year ends in June

CEO pay in FY2025Stock +52.3% in FY2025

Jack C. Bendheim is the CEO of Phibro Animal Health and was paid $5.3M in FY2025 (Jun), up 11%.

Pay$100 in the stock at the end of FY21 → $96
CEO pay is from each Phibro Animal Health proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives6

See all
  1. 1Jack C. BendheimFY2025
  2. 2Larry L. MillerFY2025
  3. 3Glenn DavidFY2025
  4. 4Daniel M. BendheimFY2025
  5. 5Judith WeinsteinFY2025
  6. 6Jonathan BendheimNot disclosed

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Phibro Animal Health paid its 5 named executives $11.2M in total in FY2025 (Jun). CEO Jack C. Bendheim was paid $5.3M of that.

Name
Jack C. BendheimChairman of the Board, President, and Chief Executive Officer
Larry L. MillerChief Operating Officer
Glenn DavidChief Financial OfficerNot disclosed
Daniel M. BendheimDirector and Executive Vice President, Corporate Strategy
Judith WeinsteinSenior Vice President, General Counsel and Corporate SecretaryNot disclosedNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers

No disclosed peer group

No proxy on file names a pay peer group for Phibro Animal Health. The peer group comes from the proxy statement, so it shows here when a proxy read has it.

Board1

See all
  • Carol A. WrennDirector · 14 yr on the boardIndependentAudit, Compensation—Paid as an executive

The board of the latest proxy (FY2024).

Activity

  1. PayDEF 14A
  2. PayDEF 14A
  3. PayDEF 14A
  4. PayDEF 14A
  5. PayDEF 14A
  6. PayDEF 14A
  7. PayDEF 14A
  8. PayDEF 14A
  9. PayDEF 14A
  10. PayDEF 14A
  11. PayDEF 14A
  12. PayDEF 14A
  13. PayDEF 14A
  14. Board3

Filings6

See all
Proxy statementDEF 14ASep 19, 2025FY2025
Annual report10-KAug 27, 2025FY2025
Proxy statementDEF 14ASep 20, 2024FY2024
Annual report10-KAug 28, 2024FY2024
Proxy statementDEF 14ASep 15, 2023FY2023
Annual report10-KAug 30, 2023FY2023